ArticleTherapeutic advances in gastroenterology2024

In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer.

Hui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.